EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS026-15924 
Organism
Homo sapiens 
Tissue/cell
CNCC 
Coordinate
chr19:8085150-8086800 
TF binding sites/motifs
Number: 28             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr19:8085786-8085804CCTTCCTTCCTTCCTTCC-10.83
EWSR1-FLI1MA0149.1chr19:8085718-8085736TCTGTCTCCCTTCCTTCC-6.32
EWSR1-FLI1MA0149.1chr19:8085702-8085720CTTTCTTTCCTTTCTTTC-6.33
EWSR1-FLI1MA0149.1chr19:8085749-8085767TTTTCCCTCCTTCCCTCC-6.33
EWSR1-FLI1MA0149.1chr19:8085798-8085816CCTTCCTTTTTTCCTTCT-6.47
EWSR1-FLI1MA0149.1chr19:8085802-8085820CCTTTTTTCCTTCTTTCC-6.56
EWSR1-FLI1MA0149.1chr19:8085730-8085748CCTTCCTTCCTTTCTTTT-6.98
EWSR1-FLI1MA0149.1chr19:8085757-8085775CCTTCCCTCCTTTCTTTC-6.98
EWSR1-FLI1MA0149.1chr19:8085753-8085771CCCTCCTTCCCTCCTTTC-7.52
EWSR1-FLI1MA0149.1chr19:8085790-8085808CCTTCCTTCCTTCCTTTT-7.95
EWSR1-FLI1MA0149.1chr19:8085722-8085740TCTCCCTTCCTTCCTTCC-8.31
EWSR1-FLI1MA0149.1chr19:8085794-8085812CCTTCCTTCCTTTTTTCC-8.34
EWSR1-FLI1MA0149.1chr19:8085782-8085800CTCTCCTTCCTTCCTTCC-8.99
EWSR1-FLI1MA0149.1chr19:8085726-8085744CCTTCCTTCCTTCCTTTC-9.6
Foxd3MA0041.1chr19:8085302-8085314AAACAAACAAAC-6.32
Foxd3MA0041.1chr19:8085306-8085318AAACAAACAAAC-6.32
HES2MA0616.2chr19:8086703-8086713GGCACGTGCC+6.02
HES2MA0616.2chr19:8086703-8086713GGCACGTGCC-6.02
HSF1MA0486.2chr19:8086254-8086267GAACCTTCTAGAA-6.74
IRF1MA0050.2chr19:8085765-8085786CCTTTCTTTCTCTTTCTCTCT+6.67
ZBTB18MA0698.1chr19:8085960-8085973ATTCCAGATGTTT+6.36
ZNF263MA0528.1chr19:8085722-8085743TCTCCCTTCCTTCCTTCCTTT-6.07
ZNF263MA0528.1chr19:8085778-8085799TTCTCTCTCCTTCCTTCCTTC-6.12
ZNF263MA0528.1chr19:8085794-8085815CCTTCCTTCCTTTTTTCCTTC-6.13
ZNF263MA0528.1chr19:8085786-8085807CCTTCCTTCCTTCCTTCCTTT-6.16
ZNF263MA0528.1chr19:8085749-8085770TTTTCCCTCCTTCCCTCCTTT-6.52
ZNF263MA0528.1chr19:8085741-8085762TTCTTTTCTTTTCCCTCCTTC-6.72
ZNF263MA0528.1chr19:8085782-8085803CTCTCCTTCCTTCCTTCCTTC-6.76
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr1980863378086511
Enhancer Sequence
TGGTGGCACA TGCCTGTAAT CCCAGCTACT TGGGAGGCTG AGGCAGGAGA AAGGCAGGAG 60
AATCGCTTGG ACCCAGGAGT CGGAGGTTGC TGTGAGGTGA GATCGTGCCA CTGCACTCCA 120
GCTTGGGCGA CAGAGTGAGA TCTGTCTTGA ACAAACAAAC AAACAAACAA AGAATTTATC 180
TTTTAACTGA AAGAGTTTAA AACTGAGAGA CTTACGTGAG TCTCTCTCTC TTTTTTTTTT 240
TTTTTGAGAC GGAGTTTCGC ACTTGTTGCC TAGGCTGGAG TGCAATGGCG TGATCTTGGC 300
TCACCGCAAC CTCTGCCTCT TGGGTTCAAG CAATTTTCCT CCTGCCTCAG CCTCCCGAGT 360
AGCTGGGATT ACAGGCATGT GCCACCATGC GGGGCTAATT TTGTATTTTT ATTAGAGGTG 420
GGGTTTCTCT ATGTTGATCA GGCTGGTCTC GAACTCCCAA CCTCAGGTGG TCTACCCACC 480
TCGGCTTCCC AAAGTGCTGG GATTACAGGC GTGAGCCATG GTGCCCGGCC GTCTCTGTCT 540
CTTAATTTCT CTCTTTCTTT CCTTTCTTTC TGTCTCCCTT CCTTCCTTCC TTTCTTTTCT 600
TTTCCCTCCT TCCCTCCTTT CTTTCTCTTT CTCTCTCCTT CCTTCCTTCC TTCCTTTTTT 660
CCTTCTTTCC GCGGGAACCT GGGGCAAGTA GAAGATACAA CATGAGAAGG GGGAGGCCTC 720
CAGGGAGGCC ATCTAGACAA CTGAAAGAGA GACGGCAAAG TGGACTGGTG GCCGGAGGAG 780
TGCTGGAGGG TTCTGGAGAG AAGGAGGCTG ATTCCAGATG TTTAAGATGT GGGGTCAGCA 840
GGACCCTGGG TGACCAGTGA AATGTGGAGA AGGTGGCAGC CAGGTCAATT AGAGACAGAT 900
GTGGGGGAAA GCCATTCTCT CTCAGAATTC TGGAGGGTTC CATATATGGG ATGGAGTTAT 960
TCTGGGGACA TCATAAGAAA TGGGTGTGCC TGTCAGGCGA GCAGTTCACT TGTCAGCCCC 1020
CACACAGAGC TGAAGCATCA TAGCCCACCC CAGTTCACTG CCCACTCTGA AAACAGAAGC 1080
CGGGCAAGCT CCAAAAAGCC GGAAGAACCT TCTAGAAGCC CTGTGTTCTT CTGAGGCCCA 1140
ACTTCAATCT GATGCCATCT CAAGCGCCAG TGAGATCGGT CATAGAAGAT TAGAGGCTTT 1200
ATTTTTTCTC AGGCAGTTGA GTTTATTTTC AGGTTAGCAG CAGTTTGGAG TTCGCTTCCT 1260
GGATGAGGTC AGAGTTGGAG GGGCAGGTGG CCACAGTGTG CTGTGTGCAG AGTCCTTGCA 1320
GCCACGACAC TTTGGCCGTT CTACCTTGTG CACAGTTCTG TCTCAAAGAG ACTGGCCCCA 1380
AAGCAGGCAC AGAAATACCA GGCTTACTTA CTTACTTACT TTATTTATTT GTTTATTTTT 1440
GAGATGGAGT CTCACTCTGT CGCCAGGCTG GAGTGATCTC GGCTCACTGT AACCTCCGCA 1500
TCCTGGGTTC AAGCGATTCT CGTGCCTCAG CCTCCTGAGT AGCTGGGATT ACAGGCACGT 1560
GCCACCACAC CCAGCTAATT TTAGTGTTTT TAGTAGAGAT GGGGGTTTCA CCCTGTTGGC 1620
CAGGATGGTC TTGATCTCCT GACCTCATGA 1650